From: Survival analysis of age-related oral squamous cell carcinoma: a population study based on SEER
Clinicopathological variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | |
Age at diagnosis | ||||
18–39 | Reference | Reference | ||
40–49 | 1.19 (1.05–1.35) | 0.007 | 1.15 (1.01–1.30) | 0.034 |
50–59 | 1.43 (1.27–1.61) | < 0.001 | 1.32 (1.17–1.48) | < 0.001 |
60–69 | 1.83 (1.62–2.06) | < 0.001 | 1.66 (1.42–1.87) | < 0.001 |
70 + | 3.46 (3.07–3.89) | < 0.001 | 3.21 (2.86–3.62) | < 0.001 |
Sex | ||||
Female | Reference | Reference | ||
Male | 0.83 (0.80–0.86) | < 0.001 | 0.94 (0.90–0.97) | < 0.001 |
Marital status | ||||
Married | Reference | Reference | ||
Unmarried | 1.84 (1.78–1.90) | < 0.001 | 1.48 (1.43–1.54) | < 0.001 |
Race | ||||
White | Reference | Reference | ||
Black | 1.82 (1.73–1.92) | < 0.001 | 1.34 (1.27–1.41) | < 0.001 |
Asian or Pacific Islander | 0.96 (0.89–1.04) | 0.340 | 1.02 (0.95–1.11) | 0.566 |
American Indian/Alaska Native | 1.08 (0.86–1.36) | 0.482 | 1.04 (0.83–1.31) | 0.743 |
Location | ||||
Floor of mouth | Reference | Reference | ||
Other mouth | 0.62 (0.58–0.66) | < 0.001 | 0.60 (0.56–0.63) | < 0.001 |
Tongue | 0.65 (0.62–0.69) | < 0.001 | 0.71 (0.67–0.76) | < 0.001 |
Size | ||||
< 1 | Reference | Reference | ||
< 2 | 1.38 (1.25–1.53) | < 0.001 | 1.35 (1.22–1.49) | < 0.001 |
< 3 | 1.96 (1.79–2.16) | < 0.001 | 1.63 (1.45–1.82) | < 0.001 |
< 4 | 2.49 (2.26–2.73) | < 0.001 | 1.91 (1.69–2.16) | < 0.001 |
< 5 | 3.36 (3.05–3.70) | < 0.001 | 2.29 (2.02–2.60) | < 0.001 |
≥ 5 | 5.48 (4.98–6.03) | < 0.001 | 3.11 (2.74–3.54) | < 0.001 |
Unknown | 3.17 (2.88–3.50) | < 0.001 | 2.40 (2.09–2.75) | < 0.001 |
Treatment | ||||
No/Unknown | Reference | Reference | ||
Surgery | 0.18 (0.18–0.19) | < 0.001 | 0.30 (0.28–0.32) | < 0.001 |
Radiation | 0.44 (0.41–0.48) | < 0.001 | 0.48 (0.44–0.52) | < 0.001 |
Chemotherapy + XRT | 0.23 (0.22–0.25) | < 0.001 | 0.26 (0.24–0.27) | < 0.001 |
Surgery + XRT | 0.21 (0.19–0.22) | < 0.001 | 0.28 (0.26–0.30) | < 0.001 |
Triple therapy | 0.18 (0.17–0.19) | < 0.001 | 0.25 (0.23–0.27) | < 0.001 |
Others | 0.63 (0.58–0.70) | < 0.001 | 0.54 (0.49–0.60) | < 0.001 |
Grade | ||||
Well-differentiated | Reference | Reference | ||
Moderately differentiated | 1.15 (1.09–1.21) | < 0.001 | 1.07 (1.02–1.13) | 0.009 |
Poorly differentiated | 0.93 (0.88–0.98) | 0.006 | 0.86 (0.81–0.91) | < 0.001 |
Undifferentiated | 0.83 (0.68–1.02) | 0.079 | 0.78 (0.63–0.95) | 0.015 |
T classification | ||||
T1 | Reference | Reference | ||
T2 | 1.61 (1.53–1.69) | < 0.001 | 1.13 (1.04–1.22) | 0.004 |
T3 | 2.67 (2.52–2.82) | < 0.001 | 1.24 (1.13–1.37) | < 0.001 |
T4 | 3.84 (3.66–4.04) | < 0.001 | 1.89 (1.73–2.06) | < 0.001 |
Unknown | 1.85 (1.72–1.98) | < 0.001 | 0.82 (0.73–0.92) | < 0.001 |
N classification | ||||
N0 | Reference | Reference | ||
N1 | 1.25 (1.19–1.31) | < 0.001 | 1.36 (1.29–1.43) | < 0.001 |
N2 | 1.25 (1.20–1.30) | < 0.001 | 1.38 (1.32–1.45) | < 0.001 |
N3 | 1.71 (1.58–1.86) | < 0.001 | 1.75 (1.60–1.92) | < 0.001 |
Unknown | 2.64 (2.33–3.00) | < 0.001 | 1.44 (1.26–1.65) | < 0.001 |
M classification | ||||
M0 | Reference | Reference | ||
M1 | 4.00 (3.72–4.29) | < 0.001 | 2.54 (2.36–2.74) | < 0.001 |
Unknown | 2.50 (2.11–2.97) | < 0.001 | 1.38 (1.16–1.65) | < 0.001 |